## Atherosclerosis in Diabetes and Hypertension: Pathophysiology and Risk Factors ### Clinical Context This patient exemplifies accelerated atherosclerosis due to multiple risk factors. The question tests knowledge of: 1. How metabolic and hemodynamic factors promote atherosclerosis 2. Histological features of advanced plaques 3. The role of emerging risk factors like Lp(a) ### Correct Statements (Options 0, 1, 2) **Option 0: Diabetes and Glycated LDL** - Hyperglycemia promotes non-enzymatic glycation of LDL apolipoprotein B - Glycated LDL (glyLDL) is more atherogenic than native LDL - Enhanced uptake by macrophage scavenger receptors (SR-A, LOX-1) - Leads to accelerated foam cell formation and plaque progression - Diabetes also impairs HDL function and increases triglycerides - [cite:Robbins 10e Ch 11] **Option 1: Hypertension and Endothelial Dysfunction** - Chronic hypertension increases hemodynamic shear stress on endothelial cells - Leads to endothelial dysfunction: loss of vasodilation, increased permeability - Upregulation of adhesion molecules (VCAM-1, ICAM-1) - Increased transendothelial migration of lipoproteins and monocytes - Hypertension is a major independent risk factor for atherosclerosis **Option 2: Histology of Advanced Plaques** - **Lipid-rich necrotic core:** Contains cholesterol crystals, cellular debris, and oxidized lipids - **Fibrous cap:** Composed of smooth muscle cells, collagen (types I and III), and proteoglycans - **Shoulder regions:** Sites of plaque rupture; contain macrophages and inflammatory cells - This architecture is characteristic of vulnerable plaques prone to rupture - [cite:Robbins 10e Ch 11] ### The Incorrect Statement (Option 3) **Option 3: Lp(a) and Atherosclerotic Risk** - **This is FALSE.** Lp(a) levels are **POSITIVELY** (not inversely) correlated with atherosclerotic plaque burden - Lp(a) is an independent risk factor for premature coronary artery disease and myocardial infarction - High Lp(a) is **PROATHEROGENIC**, not protective - Lp(a) resembles LDL but contains apolipoprotein(a) linked to apoB-100 - Lp(a) impairs fibrinolysis (inhibits tissue plasminogen activator and urokinase plasminogen activator) - Promotes inflammation and smooth muscle cell proliferation - The question asks for the statement that is NOT true — this is the answer **Key Point:** Lp(a) is an **emerging, independent risk factor** for atherosclerosis and thrombotic events. It is NOT protective; elevated levels increase cardiovascular risk. **High-Yield:** Lp(a) is genetically determined (70% heritability) and is one of the few lipid parameters NOT significantly modified by diet or statins. It is increasingly recognized as a major risk factor in NEET PG and cardiology practice. ### Comparison: Protective vs. Proatherogenic Lipoproteins | Lipoprotein | Effect on Atherosclerosis | Mechanism | |-------------|---------------------------|----------| | **LDL** | Proatherogenic | Oxidation → scavenger receptor uptake → foam cells | | **Oxidized LDL (oxLDL)** | Highly proatherogenic | Direct macrophage uptake; inflammatory | | **Glycated LDL** | Proatherogenic | Enhanced scavenger receptor recognition (in diabetes) | | **HDL** | Antiatherogenic | Reverse cholesterol transport; antioxidant | | **Lp(a)** | **Proatherogenic** | Impairs fibrinolysis; pro-inflammatory; independent risk factor | | **VLDL/Triglycerides** | Proatherogenic | Remnant particles; endothelial dysfunction | ### Pathophysiology of Accelerated Atherosclerosis in This Patient ```mermaid flowchart TD A[Type 2 Diabetes]:::outcome --> B[Hyperglycemia]:::action B --> C[LDL Glycation]:::action C --> D[Enhanced Scavenger<br/>Receptor Uptake]:::action D --> E[Foam Cell Formation]:::outcome F[Hypertension]:::outcome --> G[Increased Shear Stress]:::action G --> H[Endothelial Dysfunction]:::action H --> I[Increased Permeability<br/>Upregulation of Adhesion Molecules]:::action I --> E J[High Lp(a)]:::outcome --> K[Impaired Fibrinolysis<br/>Pro-inflammatory]:::action K --> L[Accelerated Plaque<br/>Progression & Thrombosis]:::urgent E --> M[Advanced Atherosclerotic Plaque<br/>Lipid Core + Fibrous Cap]:::outcome M --> N[Plaque Rupture<br/>Acute MI]:::urgent ``` ### Risk Factor Summary for This Patient **Modifiable:** - Hyperglycemia (glycemic control) - Hypertension (antihypertensive therapy) - Dyslipidemia (statins, ezetimibe) **Non-modifiable:** - Age (52 years) - Lp(a) level (genetic; not significantly modified by standard therapies) - Duration of diabetes (20 years) **Mnemonic: CHADS for Atherosclerotic Risk Factors** - **C:** Cholesterol (LDL, Lp(a)) - **H:** Hypertension - **A:** Age - **D:** Diabetes - **S:** Smoking
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.